Government Funding Bill Released; EB-5 Program Intact Through September
As reported by Ballard Spahr in previous Alerts, many members of Congress have proposed and considered several reform measures to the U.S. Immigrant Investor Program, known as "EB-5," over the past several years. With the sunset of the EB-5 Program looming, House Appropriations Chair Rodney Frelinghuysen introduced a short-term Continuing Resolution (CR) on April 26, 2017, to continue funding federal programs and services until May 5, 2017, including the EB-5 Program.
The CR would continue funding for legislation enacted in fiscal year 2016 Appropriations legislation. Today, the House Appropriations Committee released the fiscal year 2017 Omnibus Appropriations bill to provide discretionary funding for the federal government for the current fiscal year. The Comprehensive Government Funding Bill includes a sentence that would extend the EB-5 Program to September 30, 2017, without change, if passed. (The final paragraph of Page 734 substitutes "September 30, 2017" in place of "September 30, 2015.") It remains possible that Congress could pass EB-5 legislation before September 30, 2017, in view of the numerous bills introduced this year, as previously reported by Ballard Spahr. We will issue additional Alerts as developments occur.
Subscribe for News
Join Professionals on EB5Projects.com →
This website is for informational purposes only and does not constitute an offer or solicitation to sell shares or securities. Any such offer or solicitation will be made only by means of an investment's confidential Offering Memorandum and in accordance with the terms of all applicable securities and other laws. This website does not constitute or form part of, and should not be construed as, any offer for sale or subscription of, or any invitation to offer to buy or subscribe for, any securities, nor should it or any part of it form the basis of, or be relied on in any connection with, any contract or commitment whatsoever. EB5Projects.com LLC and its affiliates expressly disclaim any and all responsibility for any direct or consequential loss or damage of any kind whatsoever arising directly or indirectly from: (i) reliance on any information contained in the website, (ii) any error, omission or inaccuracy in any such information or (iii) any action resulting therefrom.